Form 8-K - Current report:
SEC Accession No. 0001615774-16-007701
Filing Date
2016-10-21
Accepted
2016-10-21 12:48:27
Documents
2
Period of Report
2016-10-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s104371_8k.htm 8-K 14803
2 EXHIBIT 99-1 s104371_ex99-1.htm EX-99.1 28066
  Complete submission text file 0001615774-16-007701.txt   44113
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 161945849
SIC: 8731 Services-Commercial Physical & Biological Research